SCHEMBL26931936

SCHEMBL26931936

COC(=O)c1ccc(N2CCC3(CC2)OCCO3)cc1C

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.44
▸ LGMN Q99538 1/20 0.43
▸ MAPK8 P45983 2/20 0.42
▸ MAPK10 P53779 2/20 0.42
▸ MYC P01106 1/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ ALDH1A1 P00352 6/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ PRKDC P78527 1/20 0.41
▸ SIRT6 Q8N6T7 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ NPC1 O15118 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26932111 0.89 L3MBTL3 (0.41) POLBMYCKMT2AALDH1A1SMN1; SMN2
SCHEMBL17893671 0.88 PRKDC (0.53) POLBLGMNMYCKMT2AALDH1A1
SCHEMBL17893686 0.86 ALDH1A1 (0.47) POLBLGMNKMT2AALDH1A1SMN1; SMN2
SCHEMBL17893773 0.86 NPC1 (0.44) POLBLGMNMAPK8MAPK10KMT2A
SCHEMBL15238295 0.86 LGMN (0.46) POLBLGMNMAPK8MAPK10KMT2A
SCHEMBL31568638 0.84 LGMN (0.41) POLBLGMNMAPK8MAPK10KMT2A
SCHEMBL15547618 0.83 PRKDC (0.56) KMT2AALDH1A1SMN1; SMN2PRKDCMAPT
SCHEMBL15238296 0.83 ALDH1A1 (0.57) POLBLGMNKMT2AALDH1A1SMN1; SMN2
SCHEMBL31568634 0.82 ALDH1A1 (0.40) POLBLGMNMAPK8MAPK10KMT2A
SCHEMBL16056102 0.82 ALDH1A1 (0.49) POLBLGMNKMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239645-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-12-14 — — WO disclosed
WO-2023239645-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-12-14 — — WO disclosed
Send feedback